| Entry |
|
|---|
| Name |
Prinoxodan (USAN/INN) |
|---|
| Formula |
C13H14N4O2
|
|---|
| Exact mass |
258.1117
|
|---|
| Mol weight |
258.28
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
|
|---|
| Efficacy |
Cardiotonic |
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
D05612 Prinoxodan
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
D05612 Prinoxodan
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE
D05612 Prinoxodan (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 19
1 C8y C 17.9900 -15.8200
2 C8x C 17.9900 -14.4200
3 C8x C 19.1800 -13.7200
4 C8y C 20.4400 -14.4200
5 C8y C 20.4400 -15.8200
6 C8x C 19.1800 -16.5200
7 N1x N 21.6300 -13.7200
8 C5x C 22.8200 -14.4200
9 N1y N 22.8200 -15.8200
10 C1x C 21.6300 -16.5200
11 O5x O 24.0800 -13.7200
12 C1a C 24.0800 -16.5200
13 C2y C 16.8000 -16.5200
14 N2x N 16.8000 -17.9200
15 N1x N 15.5400 -18.6200
16 C5x C 14.3500 -17.9200
17 C1x C 14.3500 -16.5200
18 C1x C 15.5400 -15.8200
19 O5x O 13.1600 -18.6200
BOND 21
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 4 7 1
8 7 8 1
9 8 9 1
10 9 10 1
11 5 10 1
12 8 11 2
13 9 12 1
14 1 13 1
15 13 14 2
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 13 18 1
21 16 19 2
|
|---|
